CSIMarket Company Name, Ticker, Competitors, else..
 
Pluri Inc   (NASDAQ: PLUR)
 
Price: $1.3600 $-0.01 -0.730%
Day's High: $1.4515000581741333 Week Perf: -7.48 %
Day's Low: $ 1.31 30 Day Perf: -24.86 %
Volume (M): 15,444 52 Wk High: $ 5.17
Volume (M$): $ 0 52 Wk Avg: $3.11
Open: $1.41 52 Wk Low: $1.25



 Market Capitalization (Millions $) 14
 Shares Outstanding (Millions) 10
 Employees 54
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -27
 Cash Flow (TTM) (Millions $) -5
 Capital Exp. (TTM) (Millions $) 1

Business Description


Pluri Inc is a software development company that specializes in creating innovative and customizable solutions for businesses. They offer a wide range of services including software development, web development, mobile app development, and cloud solutions. Pluri Inc is known for its expertise in utilizing advanced technologies like artificial intelligence (AI), blockchain, and internet of things (IoT) to help businesses streamline their operations and enhance their productivity. With a highly skilled team of developers, Pluri Inc is committed to creating cutting-edge software solutions that meet the unique needs of their clients. Overall, Pluri Inc aims to empower businesses with advanced technological tools and provide them with the competitive edge they need in today's rapidly evolving digital landscape.


   Company Address: MATAM Advanced Technology Park Haifa 3508409
   Company Phone Number: 74-7108600   Stock Exchange / Ticker: NASDAQ PLUR


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDTX   -4.93%    
DNA   -0.14%    
IMCR   -1.34%    
IPSC        4.2% 
KRYS        1.93% 
RGNX   -7.45%    
• View Complete Report
   



Product Service News

Pluri Inc. Partners with Hemafund to Uphold Radiation Emergency Preparedness in Ukraine Amidst Strong Market P...

Published Thu, Mar 13 2025 4:00 AM UTC

In a significant development aimed at enhancing Ukraine’s resilience against radiation emergencies, Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR), a pioneering biotechnology firm, has entered into an exclusive collaboration agreement with Hemafund Ltd. a prominent Ukrainian umbilical cord blood bank known for its specialized clinical and research facilities in cell preservation a...
Shares

Pluri Inc. Secures Vital Investment Boost: A Step Toward Transformative Biotechnology Solutions,

Published Tue, Feb 4 2025 12:00 PM UTC

Pluri Inc. Secures $3.5 Million Investment, Paving the Way for Future GrowthPluri Inc. a leading biotechnology company based in Haifa, Israel, has successfully completed a private placement investment of $3.5 million from its major shareholder, the Merchant Adventure Fund, L.P. This recent development, announced on February 4, 2025, elevates the total financing secured by Pl...
Merger and Acquisition

Pluri Inc. Secures Strategic Investment and Expands into Sustainable Food Technologies: A Bright Future for AgTech and Biotechnology

Published Thu, Jan 23 2025 12:15 PM UTC

IntroductionOn January 23, 2025, Haifa, Israel, witnessed a remarkable financial maneuver in the biotechnology sector with Pluri Inc. (Nasdaq: PLUR; TASE:PLUR) announcing a strategic investment of $6.5 million, primarily orchestrated by renowned global investor Alejandro Weinstein. This transformative development not only signals a pivotal moment for Pluri but also shapes th...
Product Service News

PluriCDMO Leading the Charge in Innovative Biomanufacturing and Recognition in the Industry

Published Mon, Dec 30 2024 8:22 PM UTC

In an ever-evolving landscape of the life sciences sector, innovation and scalability are paramount, and few companies are embodying these ideals more effectively than PluriCDMO. Recently shortlisted for the prestigious CDMO of the Year Award at the Advanced Therapies Awards 2025, PluriCDMO is carving its niche as a premier contract development and manufacturing organization...
Product Service News

Rising to the Occasion Pluri Inc.s Ambitious Pursuit of Mass Production for PLX-R18 Amid Global Nuclear Tensions

Published Mon, Nov 25 2024 1:30 PM UTC

In an age marked by heightened global tensions, especially regarding nuclear threats, Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR), a biotechnology company based in Haifa, Israel, has placed itself at the forefront of a critical healthcare initiative. The company is evaluating its readiness to initiate mass production of PLX-R18, a promising treatment for the hematopoietic complic...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 12.67
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.29
Working Capital Ratio 0.33
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -2769.62 $
Revenues (TTM) 0.11 $
Cash Flow (TTM) -
Cash 0.93 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 19,981
Net Income per Employee (TTM) -498,981
Receivable Turnover Ratio (TTM) 5.41
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.03

Profitability Ratios Current
Gross Margin (MRQ) 33.53 %
Operating Margin (MRQ) -3913.77 %
Net Margin (MRQ) -3695.81 %
Net Cash Flow Margin (MRQ) -755.09 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Pluri Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.